Skip to main content
Signal8

Gemina Laboratories Ltd. (GLABF)

Gemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions. The firm's innovation extends to developing unique surface functionalization chemistries specifically designed for the identification of pathogens and various biological markers. A significant ongoing project is the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip intended to determine active COVID-19 infections. The company maintains its corporate headquarters in Vancouver, Canada.

Industry: Biotechnology

Gemina Laboratories Ltd. logo

Gemina Laboratories Ltd.

OTC:GLABFHealthcare
Mkt Cap$3.83M
Float43.67M
O/S76.57M
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$15K
Net Income-$1.67M
Total Assets$1.16M
Free Cash Flow-$370K
Debt & Equity
Total Debt$926K
Total Equity-$4.26M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in GLABF's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$1.16M
Liabilities$5.42M
Accounts Receivable$32K
Accounts Payable$2.37M
Inventory$0
PP&E (Net)$26K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2026-01-312025-01-312024-01-312023-01-312022-01-312021-01-31
Revenue$15K$0$0$0$0$0
YoY Growth------
Cost of Revenue$27K$81K$67K$36K$31K$9K
Gross Profit-$11K-$81K-$67K-$36K-$31K-$9K
Gross Margin-74.4%-----
Research and Development$585K$829K$1.77M$2.96M$1.93M$362K
Selling, General, and Administrative$999K$1.88M$1.86M$1.28M$1.42M$89K
Other$0$0$0$0$0$0
Total Operating Expenses$1.58M$2.71M$3.63M$4.26M$3.37M$452K
Operating Income (EBIT)-$1.6M-$2.79M-$3.63M-$4.26M-$3.37M-$460K
Operating Margin-10407.0%-----
Interest Expense$50K$117K$14K$0$384$2K
Interest Income$0$0$0$783$0$0
Other Income (Expense)-$75K-$115K-$93K$200K$125K-$179K
Income Before Tax (EBT)-$1.67M-$2.9M-$3.72M-$4.26M-$3.38M-$595K
Income Tax Expense$0$0$0$0$0$0
Net Income-$1.67M-$2.9M-$3.72M-$4.26M-$3.38M-$595K
Net Income Margin-10893.2%-----
Supplementary Data
EPS-0.03-0.06-0.07-0.10-0.10-0.02
Diluted EPS-0.03-0.06-0.07-0.10-0.10-0.02
Weighted Average OS76.18M74.06M72.45M60.19M47.66M50.24M
EBITDA-$1.57M-$2.71M-$3.64M-$4.23M-$3.34M-$452K
EBITDA Margin-10232.5%-----
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2026-01-312025-01-312024-01-312023-01-312022-01-312021-01-31
Assets
Current Assets
Cash and Cash Equivalents$343K$501$706$59K$824K$629K
Short-Term Investments$0$0$0$0$0$11K
Cash and Short-Term Investments$343K$501$706$59K$824K$640K
Accounts Receivable$32K$25K$27K$275K$7K$11K
Inventory$0$0$0$0$0$1.1M
Other Current Assets$29K$0$0$0$0$1.1M
Total Current Assets$404K$76K$66K$401K$983K$1.74M
Long-Term Assets
Property, Plant & Equipment Net$26K$224K$263K$226K$29K$33K
Goodwill$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0
Long-Term Investments$710K$709K$709K$709K$0$7K
Deferred Tax Assets$0$0$0$0$0$0
Other Long-Term Assets$16K$16K$0$0$0$18K
Total Long-Term Assets$752K$949K$972K$935K$29K$58K
Other Assets$0$0$0$0$0$0
Total Assets$1.16M$1.03M$1.04M$1.34M$1.01M$1.8M
Liabilities
Current Liabilities
Accounts Payable$2.37M$2.04M$1.19M$662K$232K$60K
Short-Term Debt$926K$712K$143K$0$0$0
Current Income Tax Payable$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$23K
Other Current Liabilities$2.12M$0$527K$0$0$1.54M
Total Current Liabilities$5.42M$4.06M$2.02M$1.25M$335K$1.66M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0
Total Long-Term Liabilities$0$125K$147K$141K$4K$27K
Other Liabilities$0$0$0$0$0$0
Total Liabilities$5.42M$4.19M$2.17M$1.39M$339K$1.69M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0
Common Stock$9.12M$8.54M$8.01M$5.81M$4.01M$709K
Retained Earnings-$16.55M-$14.85M-$11.95M-$8.23M-$3.97M-$595K
Comprehensive Income & Other$3.16M$3.15M$2.78M$2.37M$635K$0
Other Stockholders' Equity$3.16M$3.15M$2.81M$2.37M$635K$0
Total Equity-$4.26M-$3.16M-$1.13M-$51K$673K$114K
Minority Interest$0$0$0$0$0$0
Total Liabilities and Equity$1.16M$1.03M$1.04M$1.34M$1.01M$1.8M
Supplementary Data
Total Debt$926K$908K$346K$172K$33K$70K
Net Debt$583K$907K$345K$112K-$791K-$559K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
CurrencyUSDUSDUSDUSDUSDUSD
Period Ending2026-01-312025-01-312024-01-312023-01-312022-01-312021-01-31
Operating Activities
Net Income-$1.67M-$2.9M-$3.72M-$4.26M-$3.38M-$595K
Depreciation & Amortization$27K$81K$67K$36K$31K$9K
Deferred Income Tax$0$0$0$0$0$0
Stock-Based Compensation$0$370K$403$280K$501K$0
Changes in Working Capital:
  Accounts Receivable-$8K$3K$248-$143K-$124K-$3K
  Inventory$0$0$0$0$0$0
  Accounts Payable$0$0$0$0$0$0
  Other Working Capital$1.2M$1.42M$47$867K$204K$102K
Total Working Capital Change$1.19M$1.42M$295$724K$80K$100K
Other Non-Cash Items$80K$103K$1.34M$7K$3K$279K
Net Cash from Operating-$370K-$927K-$2.31M-$3.21M-$2.76M-$227K
Investing Activities
Capital Expenditures$0$0-$29K-$57K-$7K$0
Acquisitions$0$0$0$0$0$24K
Purchases of Investments$0$0$0-$306K$0$0
Sales of Investments$0$0$0$0$0$0
Other Investing Activities$0$13K$0$3K$13K-$14K
Net Cash from Investing$0$13K-$29K-$360K$6K$10K
Financing Activities
Debt Repaid--$565K$64K$45K$48K-
Common Stock Issuance-$5K$0$1.86M$3.06M$1.72M$1.94M
Common Stock Repurchases$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0
Other Financing Activities-$22K$349K$348K-$209K$1.27M$1K
Net Cash from Financing$713K$914K$2.28M$2.81M$2.95M$1.94M
Forex Effect$31$0$0$0$0$0
Net Change in Cash$343K-$205-$59K-$765K$196K$1.72M
Supplementary Data
Operating Cash Flow-$370K-$927K-$2.31M-$3.21M-$2.76M-$227K
Capital Expenditure$3$0-$29K-$57K-$7K$0
Free Cash Flow-$370K-$927K-$2.34M-$3.27M-$2.77M-$227K
Cash at Beginning$471$706$59K$824K$629K$0
Cash at End$343K$501$706$59K$824K$1.72M